INVO Fertility Approves 1-for-20 Reverse Stock Split
Ticker: IVF · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1417926
| Field | Detail |
|---|---|
| Company | Invo Fertility, INC. (IVF) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: reverse-split, compliance, nasdaq
TL;DR
INVO Fertility doing a 1-for-20 reverse split to stay on Nasdaq. Big deal if they want to keep trading.
AI Summary
On July 9, 2025, INVO Fertility, Inc. announced that its Board of Directors approved a reverse stock split of its common stock at a ratio of 1-for-20. This action is intended to increase the per-share market price of its common stock to meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
Why It Matters
This reverse stock split is a strategic move to comply with Nasdaq listing rules, aiming to prevent delisting and maintain investor confidence.
Risk Assessment
Risk Level: medium — Reverse stock splits can signal underlying business challenges and may not always succeed in boosting stock price long-term.
Key Numbers
- 1-for-20 — Reverse Stock Split Ratio (To increase share price and meet Nasdaq minimum bid requirement.)
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- Nasdaq Capital Market (company) — Exchange where stock is listed
- July 9, 2025 (date) — Date of Board approval
- 1-for-20 (other) — Ratio of reverse stock split
FAQ
What is the primary reason for INVO Fertility's reverse stock split?
The primary reason is to increase the per-share market price of its common stock to meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
When was the reverse stock split approved by the Board of Directors?
The reverse stock split was approved by the Board of Directors on July 9, 2025.
What is the ratio of the approved reverse stock split?
The approved reverse stock split is at a ratio of 1-for-20.
What stock exchange is INVO Fertility seeking to remain listed on?
INVO Fertility is seeking to remain listed on the Nasdaq Capital Market.
What is the expected effective date of the reverse stock split?
The filing does not specify the exact effective date, but it was approved on July 9, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding INVO Fertility, Inc. (IVF).